Skip to content

Rafael Holdings, Inc. RFL Deferred Tax Assets, Gross

Deferred Tax Assets, Gross at other companies

Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.

The official record: Rafael Holdings, Inc.’s 10-K, filed October 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s deferred tax assets, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s deferred tax assets, gross?
Rafael Holdings, Inc. (RFL) reported deferred tax assets, gross of $137.42M in Q2 2025.
What is the long-term trend for Rafael Holdings, Inc.'s deferred tax assets, gross?
Over 2 years (2023 to 2025), Rafael Holdings, Inc.'s deferred tax assets, gross has grown at a 64.4% compound annual growth rate (CAGR), from $50.87M to $137.42M.